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AbSTRAcT
background: Renal allograft artery stenosis is the most preva-
lent vascular complication after renal transplantation. The 
diagnostic limitations of noninvasive tests are well defined 
and angiography remains the gold standard for diagnosis and 
therapeutic definition. The use of fractional flow reserve for 
a better stratification of native renal artery stenosis may be 
useful for an adequate selection of patients for percutaneous 
treatment, however this method has not yet been validated 
in patients undergoing transplantation. The objective of this 
study is to describe and standardize the fractional flow re-
serve protocol in patients with renal allograft artery stenosis 
in a group of patients selected for percutaneous renal inter-
vention, correlating the method with angiography Methods: 
Cross-sectional, single center pilot study (Hospital São Paulo/ 
Universidade Federal de São Paulo, São Paulo, SP, Brazil), 
including 10 patients with a clinical picture compatible with 
renal allograft artery stenosis, with angiography showing graft 
stenosis > 60% and admitted for percutaneous renal interven-
tion. Graft dysfunction assessment will include biomarkers of 
renal function. conclusions: In this study, a fractional flow 
reserve protocol for the functional assessment of renal allograft 
artery stenosis will be standardized, evaluating an alternative 
method capable of identifying patients most likely to benefit 
from percutaneous renal intervention.
 
 
 
 
 
 
DEScRIPTORS: Renal artery obstruction. Kidney transplantation. 
Renal insufficiency, chronic.
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RESUMO
Estudo RFRIST (Reserva de Fluxo Fracionada na 
Quantificação Funcional das Estenoses em Artérias de 
Rins Transplantados): Racional e Desenho do Estudo
Introdução: A estenose da artéria do enxerto renal é a com-
plicação vascular mais prevalente após transplante renal. As 
limitações dos exames não-invasivos para seu diagnóstico 
são bem definidas e a angiografia permanece como padrão 
de referência para diagnóstico e definição terapêutica. A 
utilização da reserva de fluxo fracionada renal para melhor 
estratificação das estenoses de artéria renal nativa pode ajudar 
na adequada seleção de pacientes para tratamento percutâneo, 
porém tal método ainda não está padronizado em pacientes 
submetidos a transplante. O objetivo deste estudo será des-
crever e padronizar o protocolo de reserva de fluxo fracionada 
em pacientes com estenose da artéria do enxerto renal em 
um grupo de pacientes selecionados para intervenção renal 
percutânea, correlacionando o método com a angiografia. 
Métodos: Estudo piloto, prospectivo, transversal, unicêntrico 
(Hospital São Paulo/Universidade Federal de São Paulo, São 
Paulo, SP, Brasil), em que serão selecionados 10 pacientes com 
quadro clínico compatível com estenose da artéria do enxerto 
renal, com angiografia do enxerto evidenciando estenose 
≥ 60%, admitidos para intervenção renal percutânea. Como 
avaliação da disfunção do enxerto serão realizadas dosagens 
de biomarcadores da função renal. conclusões: No presente 
estudo, um protocolo original de reserva de fluxo fracionada 
para avaliação funcional de estenose da artéria do enxerto 
renal será padronizado, avaliando um método auxiliar na 
investigação funcional que possa identificar pacientes que 
realmente se beneficiem com a intervenção renal percutânea.
DEScRITORES: Obstrução da artéria renal. Transplante de rim. 
Insuficiência renal crônica.
Study Design
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R enal transplantation has been performed for the treatment of patients with chronic renal failure since 1954. Nevertheless, renal transplantation can 
give rise to urologic, vascular, and even clinical com-
plications due to the use of immunosuppressive drugs.
Vascular complications are infrequent in kidney 
transplantations; however, they are one of the major 
causes of morbidity and mortality, occasionally result-
ing in renal graft dysfunction, graft removal, or death.1,2 
Among the vascular complications are renal graft artery 
stenosis, arteriovenous fistula, and renal vein throm-
bosis. Renal graft artery stenosis is the most common 
and occurs in 1% to 15% of transplanted patients.3-5 
According to the United States Renal Data System 
registry, 41,867 renal transplantations were performed 
in the period from 2000 to 2005, of which 823 de-
veloped renal graft artery stenosis, corresponding to a 
rate of 8.3 cases per 1,000 patient-years.6 According to 
data from the Brazilian Transplantation Registry, 19,101 
procedures were performed in that same period, but 
no data are available regarding the incidence of renal 
graft artery stenosis.7 In the present institution, Lopes 
et al.8 reported a renal graft artery stenosis rate of ap-
proximately 1.6%. 
Although no specific study has confirmed the associa-
tion between vascular complications and graft position, 
the most often used technique is graft implantation in 
the common iliac or external artery, using termino-lateral 
anastomosis due to its speed and simplicity. The main 
causes of renal graft artery stenosis are inappropriate 
suture due to technical failure, intimal lesion during 
graft perfusion or when performing the implant, and 
excessive length of the renal artery causing torsion or 
tension at the suture site.1,4-9 Atherosclerosis and fibrosis 
at the anastomosis site are also causes of renal artery 
stenosis, and generally occur at a later stage after 
transplantation.9 
In general, clinical findings that suggest renal graft 
artery stenosis are severe arterial hypertension refractory 
to drug treatment, and audible murmur at the site of 
the graft associated with unexplained progressive graft 
dysfunction. The presence of hypertension in renal 
transplantation recipients is a clinical finding in 50% 
to 60% of cases in the long-term.9,10 In the study by 
Mendes et al.,9 in all cases of haemodynamically sig-
nificant renal graft artery stenosis (defined as stenosis 
> 60%), there was progressive loss of graft function and 
difficult-to-control hypertension (with the use of three 
or more antihypertensive drugs).
Colour Doppler ultrasonography is an excellent 
diagnostic method for initial assessment of renal graft 
artery stenosis, with a sensitivity of 94% and a specificity 
of 87% when compared to conventional angiography.10 
Computed tomography angiography (CTA) has a sensiti-
vity and a specificity of 100% and 96%, respectively; 
its disadvantages are the use of ionising radiation and 
iodinated contrast.11 Magnetic resonance angiography 
(MRA) using gadolinium has been shown to be a good 
method for the detection of renal artery stenosis. Korst 
et al.12 found a sensitivity and a specificity of 100% 
and 85%, respectively. It is an excellent technique for 
patients with impaired renal function and allergy to 
iodinated contrast medium, in whom digital angiography 
cannot be performed.13
In general, all patients submitted to renal trans-
plantation at this institution who have high clinical 
suspicion of graft stenosis undergo Doppler ultrasound 
assessment, and when the results are altered (peak 
systolic velocity > 180 cm/s), a renal angiography is 
indicated. Angiography, an examination considered to 
be the gold standard for the definitive diagnosis of renal 
artery stenosis, is used to confirm the injury indicated 
by Doppler ultrasonography and/or CTA, and guides 
the therapeutic approach. However, angiography is 
based on findings of visual estimation or by quantita-
tive renal angiography (QRA), thereby determining the 
severity of a stenosis while quantifying t. Stenoses are 
considered severe when there is > 60% of vessel lu-
men obstruction.7,11
Once the diagnosis is attained, treatment options 
include percutaneous treatment using a conven-
tional percutaneous intervention with a balloon or, 
preferably, stenting (percutaneous renal intervention 
[PRI]) and revascularisation surgery. The PRI results 
in resolution or improvement in 76% of cases, with 
the discontinuation of at least two antihypertensive 
medications, and in some patients already on dialy-
sis, it is possible to achieve graft function recovery.7 
Success rates are high, and restenosis with stenting is 
below 10%, mainly due to the high luminal diameter 
of the vessel and the immunosuppressive therapy used 
after transplantation.7,9
In contrast, some patients submitted to renal graft 
angiography have moderate stenosis (> 30% and < 60%), 
in addition to cases in which the visual estimation/
QRA cannot define the actual severity of the stenosis. 
This usually occurs in stenosis with ostial location or 
even as a result of the limitations of luminography. In 
this scenario, the idea of using a method that would 
help in the functional stratification of renal graft artery 
stenosis has been proposed. Developed and validated 
for the functional stratification of coronary stenosis, the 
fractional flow reserve for native renal artery stenosis 
has been studied by Leesar et al.14 and Kapoor et al.15 
These studies evaluated the severity of stenosis based 
on the maximum and mean translesional systolic pres-
sure gradients, and based on the association between 
maximum systolic pressure in the aorta and pressure 
distal to the stenosis (Pd/Pa), measured by the pressure 
wire during maximum hyperaemia induced by 30 mg 
papaverine infused as an intrarenal bolus. To predict 
the severity of native renal artery stenosis, accuracy, 
sensitivity and specificity of 84%, 82%, and 84% were 
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determined, respectively, for maximum systolic gradient 
>  21  mmHg, and 79%, 82%, and 88%, respectively, 
for a Pd/Pa ratio < 0.9.
Regarding renal graft artery stenosis, there have 
been no studies that used fractional flow reserve for 
the functional analysis of these stenoses. Thus, the 
usefulness of this method in the functional evaluation 
of these patients and the possibility of predicting the 
therapeutic effectiveness of the PRI has not yet been 
explored.
Methods
Fractional flow reserve: definitions  
and principles
Renal fractional flow reserve is defined as the ratio 
between the maximum blood flow to the renal paren-
chyma in the presence of a determined stenosis (or 
stenoses) and this same flow if there were no stenoses. 
This ratio represents the fraction of normal maximum 
renal flow that can be achieved in the presence of 
stenosis. The fractional flow reserve can be readily 
determined by dividing the mean pressure distal to the 
renal lesion by the mean pressure in the aorta during 
maximal vasodilation induced by administering an 
intra-arterial bolus dose of 30 mg papaverine in the 
renal graft. A fractional flow reserve of 0.6 indicates 
that the maximum amount of blood (and oxygen) that 
irrigates that particular area of renal tissue is only 60% 
of what it would be if the culprit artery was completely 
normal. If, after a PRI, the fractional flow reserve in 
that case increases to 0.90, it means the maximum 
achievable flow into the parenchymal area supplied by 
that artery (and hence, the oxygen supply) increased 
by 50% and is now 90% of the attainable value if the 
artery was completely normal. Figures 1 and 2 show, 
schematically, how to determine the fractional flow 
reserve and how the flow measurement can be inferred 
by dividing pressures.
Protocol description 
Study goals
 1. To describe and standardise the study protocol of 
fractional flow reserve in patients with severe ste-
nosis of the renal graft artery who are selected for 
PRI, observing whether the cutoff used for native 
renal artery stenosis (maximum systolic gradient > 
21 mm or Pd/Pa < 0.9) is reproducible for renal 
graft artery stenosis.
 2. To compare the results obtained through direct 
measurements of pressure gradients (pre- and post-
stenosis) at rest and after hyperaemic stimulation 
performed with a conventional 4F catheter, as well 
as the pressure measured by the pressure wire.
Figure 1 – Definition of renal fractional flow reserve. If there is no stenosis (gray lines), the perfusion pressure determines the maximum normal flow 
rate (100%) of the renal parenchyma (Pa = Pd). In case of stenosis (black lines), responsible for a gradient of 30 mmHg during maximum hyperaemia, 
the distal perfusion pressure will decrease to 70 mmHg. As the ratio between renal flow and pressure is linear during hyperaemia (chart), renal flow 
will reach only 70% of its normal value. Pa, perfusion pressure, Pd, distal pressure.
Renal flow during hyperaemia (% of normal)
Perfusion pressure during hyperaemia (% of normal)
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 3. To evaluate the association between fractional flow 
reserve values before and after the procedure and 
procedural success through ultra-sensitive markers 
of renal function.
Study population
A total of ten 15 to 65 year-old patients will be 
initially assessed, after an informed consent is signed. 
The patients will have been referred to the Interven-
tional Cardiology Service of the Hospital São Paulo 
(Escola Paulista de Medicina, Universidade Federal 
de São Paulo (UNIFESP/EPM), São Paulo, SP, Brazil), 
with a clinical picture of renal graft artery stenosis, 
associated with Doppler ultrasound and/or CTA 
suggestive of renal graft artery stenosis to undergo 
renal angiography and, when the presence of this 
stenosis is confirmed, will have an indication for 
PRI (renal graft artery stenosis ≥ 60% at visual esti-
mation). The project was approved by the research 
ethics committee, protocol No. 51,518 – Plataforma 
Brasil – Brazilian Ministry of Health. Figure 3 sum-
marises the study design. Patients will be admitted 
12 hours before the procedure, and intravenous 
hydration will be carried out with 0.9% saline solu-
tion at 1 mL/kg/hour, 12 hours before and after the 
test. Low-osmolarity contrast will be used to minimise 
the risk of contrast-induced nephropathy. Dual anti-
platelet therapy will be administered (with 300 mg 
acetylsalicylic acid and 300 mg clopidogrel, 12 hours 
prior to the procedure). A dose of 100 mg acetylsali-
cylic acid will be maintained indefinitely, as well as 
75 mg clopidogrel for 30 days.
The angiograms of all patients selected for the 
study will be analysed by an experienced interventional 
physician. Then, artery lesions considered to be severe 
(visual estimates showing stenosis ≥ 60%), and thus with 
an indication for PRI, will be submitted to the proto-
col for the analysis of the mean systolic translesional 
pressure gradients and fractional flow reserve pre- and 
post-treatment under hyperaemia with papaverine.
Materials
6F or 7F therapeutic guide-catheters without lat-
eral holes will be used for selective catheterisation 
of the artery to be approached. The measurement of 
the translesional pressure gradient will be mandatorily 
performed with 4F guide catheters, as larger-calibre 
catheters interfere with the assessment of stenosis du-
ring their retreat to perform the gradient measurement. 
The guidewire to be used for measurement of fractional 
flow reserve uses a specific sensor located 3 cm from 
its tip, has a diameter of 0.014 inch (0.36 mm), and 
has a soft tip, similar in calibre to the guide wires 
routinely used in PRI procedures. PressureWire Certus 
Hydrophilic® guidewires (Radi Medical Systems AB 
Inc., Uppsala, Sweden) will also be used. The guide 
wire is connected to a monitor, which, by converting 
the pressure signal to an electrical signal, presents the 
results directly on the screen, allowing the data to be 
viewed and saved in a few seconds.
The angiograms will be performed with Philips Allure 
FD10 equipment (flat panel), which has software with 
appropriate settings for acquisition and processing of 
images in rotational angiography of the abdomen.
Hyperaemia
It is essential to induce maximal vasodilation 
in the two compartments of renal circulation, in the 
vessel itself and in the microcirculation, to calculate 
the renal fractional flow reserve. Administration of 
30 mg papaverine by an intra-arterial route in bolus 
is the available option. The drug’s action lasts up to 
50 seconds; it has no side effects and can be used in 
catheter withdrawal manoeuvres. The systolic and mean 
translesional gradients are calculated simultaneously 
during the analysis of the renal fractional flow reserve. 
Systematisation for the initial angiographies, 
angiographic definition of lesion severity, 
measurement of renal fractional flow reserve,  
and PRI with a stent and new measurement  
of fractional flow reserve.
A total of ten patients who have a clinical picture 
of renal artery graft stenosis and angiography showing 
graft stenosis ≥ 60% and are admitted to undergo PRI 
will be selected. For the evaluation of graft dysfunc-
tion, serum measurements of urea and creatinine will 
be performed 12 hours before and 12 and 72 hours 
after the procedure. Measurement of urinary neutrophil 
gelatinase-associated lipocalin (NGAL), interleukin-18 
(IL-18), kidney injury molecule-1 (KIM-1), and serum 
cystatin C will be performed at the beginning and 6 
hours, 12  hours, 24 hours, and 48 hours after the 
procedure.
Figure 2 – Renal fractional flow reserve is calculated by dividing the 
distal pressure in the renal artery by the pressure in the aorta during 
maximum hyperaemia. FFR, fractional flow reserve, QStenosis, flow in 
renal graft artery with stenosis; QNormal, flow in the renal graft artery 
in the absence of stenosis; Pd, distal pressure; PV, venous pressure; PA, 
pressure in the aorta; RMIO, renal resistance.
Hydraulic equation
Pressure (∆P) = Flow (Q) × Resistance (R)
Q = ∆P/R
QStenosis
QNormal
FFRmio
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The following steps will be performed during the 
procedure:
 1. Local anaesthesia of the arterial puncture site with 
2% lidocaine (10 – 15 mL).
 2. Insertion of a 6F or 7F arterial sheath. 
 3. Introduction of a 4F Judkins right (JR) catheter after 
the stenosis and maximum hyperaemia induced with 
30 mg papaverine in bolus followed by evaluation 
of translesional gradients. 
 4. Selective catheterisation of the renal graft artery 
with an RDC guide catheter or a JR 4 of PRI, 6F, 
or 7F without lateral holes.
 5. Administration of 100 UI/kg IV heparin.
 6. Calibration of guide-catheter and pressure wire.
 7. Connection of the pressure wire to the analyser, 
equating the pressures of the guide-catheter and 
wire pressure when the sensor of the latter is close 
to the tip of the guide-catheter.
 8. Placement of the pressure wire in the distal bed 
of the renal graft artery to be analysed.
 9. Evaluation of graft stenosis by measuring the frac-
tional flow reserve during maximum hyperaemia 
induced by an intra-arterial injection of 30 mg 
papaverine in bolus in the renal graft.
10. Performing PRI with stent implantation.
11. New gradient assessment through maximum hy-
peraemia with papaverine using the pressure wire 
and a 4F catheter.
Procedural success analysis 
Angiographic success
Procedural angiographic success will be considered 
when the stenosis is resolved after the PRI (residual 
≤ 30%)7 with no major complications.
Functional success
Following the principles established by the hydraulic 
equation to calculate the renal fractional flow reserve 
as shown in Figure 2, after normalising the flow with 
the resolution of the previously existing stenosis, there 
should be no pressure difference between the pressure 
distal to the treated site and the proximal pressure (Pd 
= Pa), which means that the Pd/Pa ratio = 1. Likewise, 
the resolution of the systolic and mean translesional 
pressure gradients can be estimated.
To analyse renal function improvement, kidney injury 
markers, which have been developed and validated to 
predict the degree of renal dysfunction, will be quan-
tified. The most commonly used laboratory parameter 
for the clinical diagnosis of acute renal failure (ARF) 
Figure 3 – Overview of the study protocol. RGAS, renal graft artery stenosis; Echo, echocardiography; CTA, computed tomography angiography; 
FFR, fractional flow reserve; PRI, percutaneous renal intervention; Ur, urea; Cr, creatinine; NGAL, neutrophil gelatinase-associated lipocalin; IL-18, 
interleukin-18; KIM-1, kidney injury molecule-1.
Ten patients underwent renal
transplantation with a strong
clinical suspicion of RGAS.
Realization of renal FFR bolus of papaverine and
obetenção mázimo with gradients and medium pressure
wire and catheter 4F or 5F.
Age between 10 and 65 years.
Unrestricted qanto
comorbidities.
Exclusion of other
potential causes of graft
dysfunction.
Angiography showing stenosis
≥ 60%. Indication of PRI.
Review fos gradients
and renal FFR to RGAS.
Artery angioplasty
of the renal graft.
New evaluation of
gradients and renal FFR.
Serum Cr and Ur 12h and 12h
pre-PRI and 72h. Dosages urinary
NGAL, Il-18 and KIM-1 at the
beginning of the procedure, 6h, 
12h, 24h and 48h. Serum cystatin
C at the beginning of the
procedure, 6h, 12h, 24h and 48h.
Eco Doppler peak 
systolic velocity greater 
≥ to 180cm/ and/or 
suggestive of Echo RGAS.
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is the elevation in plasma creatinine. However, it is 
necessary that the glomerular filtration rate is reduced 
by 50% in order to increase the creatinine. The ideal 
biomarker should be quick and easy to measure, ob-
tainable through minimally invasive procedures, and 
capable of detecting early tubular injury and reflect-
ing changes of renal function. Currently, KIM-1, IL-18, 
NGAL, and cystatin C are considered as the urinary 
molecules with the greatest potential for early detection 
of acute kidney injury for clinical use.16,17
Parikh et al.18 evaluated the urinary measurement 
of NGAL associated with lipocalin in 63 patients sub-
mitted to renal transplantation and found a sensitivity 
and specificity of 90% and 83%, respectively, to predict 
ARF (cutoff of 53 pg/mL) measured two hours after 
transplantation. The same authors also evaluated the 
measurement of IL-18 with excellent results in predict-
ing ARF in post-renal transplantation. 
Therefore, the measurements of the renal injury 
markers (IL-18, NGAL, urinary KIM-1, and serum cys-
tatin C) will be performed shortly before the procedure 
(time zero), 6, 12, 24, and 48 hours after the PRI, 
and their values will be compared with the plasma 
creatinine measured 12 hours before and 12 and 72 
hours after PRI. Consequently, it will be possible to 
assess the effects of the procedure (handling of arte-
rial stenosis, contrast-induced nephropathy) associated 
with improved perfusion of the renal parenchyma after 
stenosis resolution.
statistical analysis 
Due to the small number of patients in this pilot 
study, it is possible that much of the data will not 
be comparable. This project will serve to establish 
the submission method for a supplemental project to 
the funding agency and sample expansion. The most 
important data collected here will be the difference 
between fractional flow reserve before and after treat-
ment, assuming that the same value found in studies 
of native artery stenosis is reproduced here (fractional 
flow reserve of 0.9).
Continuous variables will be expressed as the 
means and standard deviations and compared by Stu-
dent’s t-test. Categorical variables will be described as 
absolute frequencies and compared by the chi-squared 
test. Spearman’s test will be used for the correlation 
between the haemodynamic parameters of the study and 
the percentage of renal graft artery stenosis at visual 
estimation. The Wilcoxon test will be used to compare 
the measurements of kidney injury biomarkers before 
and after stent implantation at the times described. P-
values < 0.05 will be considered indicative of statistical 
significance. All analyses will be performed using the 
SPSS 11.5 software package (SPSS – Chicago, USA). It 
is noteworthy that, due to the small sample size, there 
will not be sufficient statistical power to evaluate the 
efficiency of PRI in the context of treatment for renal 
graft artery stenosis.
ConClusions
The use of the fractional flow reserve for better 
stratification of renal graft artery stenosis may improve 
the selection of patients for percutaneous treatment, 
thus reducing risks and preserving resources. Since the 
study will be conducted with patients with confirmed 
diagnosis of severe renal graft artery stenosis (> 60%), 
and since the patients will be treated regardless of the 
values found for fractional flow reserve, it will not be 
possible to conclude that the fractional flow reserve 
is an additive method for better stratification of steno-
ses, but only that the protocol was described in this 
sample. However, the results may be of great value 
for the development of future studies, expanding the 
use of methods and refining information obtained by 
other diagnostic tests.
Thus, a future study designed is being that can 
validate the fractional flow reserve as a method to 
stratify patients who can greatly benefit from PRI in 
the clinical scenario described, using a more robust 
sample of patients. 
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